Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Effect of Bevacizumab Alone or in Combination with Triamcinolone for Diabetic Macular Edema
IRCT2014080818733N1Phase 3Completed
- Sponsor
- vice-chancellor for research-Tehran University of Medical Science
- Start
- Oct 2014
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, Monoclonal Antibodies → Antibody-Based Therapeutics
- Countries
- 1
01
Overview
Phase 3 trial of bevacizumab and triamcinolone in diabetic macular edema (DME) (2 arms), sponsored by vice-chancellor for research-Tehran University of Medical Science. Started Oct 2014; status: completed.
02
Drugs
bevacizumabtriamcinolone
03
Conditions
diabetic macular edema (DME)
Beyond the preview
Go deeper on IRCT2014080818733N1.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT2014080818733N1.